Skip to main content Skip to left-side content

Submit an Event

You must have an active OUHSC user account to submit events.

Login
Calendar
Title and navigation
<<<Nov 2014>>>
Nov 2014
SunMonTueWedThuFriSat
2627282930311
2345678
9101112131415
16171819202122
23242526272829
30123456

Grand Rounds and Seminars

Feb20
Medicine Grand Rounds
2/20/2013 12:15 PM - 1:15 PM
Basic Sciences Education Building, E. Lecture Hall
Title:
Angioedema:  A Tale of Two Peptides

Speaker:
Bruce Zuraw, MD, Professor of Medicine-in-Residence, University of California, San Diego
  
Objectives:             
Upon completion of this activity, participants will be able to:  Identify the differential diagnosis of angioedema.  To recognize the pathophysiology of angioedema.  To formulate a diagnosis of angioedema.  To assess treatment of angioedema.

Disclosure Report: 
Course Director:  Dr. Michael Bronze has no financial relationships or affiliations to disclose.  Planning Committee Members:  Dr. Ben Cowley has been a consultant for Otsuka.  Dr. Douglas Drevets has received grants/research support from NIH.  He has received honorarium from NIH and NIAID.  Dr.  Courtney Houchen has received other financial or material support in that he is the Founder of COARE Biotechnology.  Dr. Tim Lyons has received grants/research support from Merck Sharp & Dohme, Andromeda Biotech, Novo Nordisk, Boehringer-Ingelheim, Corcept Therapeutics, and Registry.  Dr. Dwight Reynolds has received grants/research support from Medtronic.  He has been a consultant for Medtronic and Sorin.  He has received honorarium from Medtronic and Sorin.  Dr. Ira Targoff has been a consultant for the OMRF Clinical Immunology Lab and has received honorarium from Up-to-Date.  Drs. Jackson, Kinasewitz, Selby and Zou have no financial relationships or affiliations to disclose.  Course Contact:  Ms. Brenda Wilkerson has no financial relationships or affiliations to disclose.  Speaker:  Dr. Zuraw has grants/research support from Shire HGT.  Dr. Zuraw is a consultant for CSL Behring, Dyax, Isis, BioCryst, Sanofi-Aventis, Novartis, and Genentech.  Dr. Zuraw has received honorarium from Dyax.

Disclaimer Statement:  
Statements, opinions and results of studies contained in the program are those of the presenters/authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability.  Every reasonable effort has been made to faithfully reproduce the presentations and material as submitted.  However, no responsibility is assumed by OU for any claims, injury and/or damage to persons or property from any cause, including negligence or otherwise, or from any use or operation of any methods, products, instruments or ideas contained in the material herein.

For further information contact:
Brenda Wilkerson
271-6651 x6 (54374)
brenda-wilkerson@ouhsc.edu
Number of CE Credits: 0